KKL-35

• Description :

  KKL-35 is a trans-translation tagging reaction inhibitor with an IC50 of 0.9 μM.

• UNSPSC :

  12352005

• Hazard Statement :

  H302

• Target :

  Bacterial

• Type :

  Reference compound

• Related Pathways :

  Anti-infection

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Infection

• Assay Protocol :

  https://www.medchemexpress.com/KKL-35.html

• Purity :

  99.46

• Solubility :

  DMSO : 6.25 mg/mL (ultrasonic)

• Smiles :

  O=C(NC1=NN=C(C2=CC=C(F)C=C2)O1)C3=CC=C(Cl)C=C3

• Molecular Formula :

  C15H9ClFN3O2

• Molecular Weight :

  317.70

• Precautions :

  H302

• References & Citations :

  [1]Ramadoss NS, et al. Small molecule inhibitors of trans-translation have broad-spectrum antibiotic activity. Proc Natl Acad Sci U S A. 2013 Jun 18;110 (25) :10282-7.

• Shipping Conditions :

  Room Temperature

• Storage Conditions :

  -20°C, 3 years; 4°C, 2 years (Powder)

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [865285-29-6]